ghk cu clinical trial skin anti aging randomized double blind GHK-Cu Cooper Peptide: The Complete & Repair Guide (2026) GHK-Cu Copper Peptides: 50 Years
Description
First Study of Intravenous BPC-157 in Humans Shows No Side Effects in Two Patients. Alternative therapies in health and medicine.Study breakdown PubMed 4RPEP-05534Lee, Edwin et al
Is BPC-157 right for you
10.1038/gt.2017.12 Gene Ther
However, none of these studies have specifically selected children with mitochondrial dysfunction or disease to study, so it is difficult to know if individuals with ASD and mitochondrial dysfunction would benefit the most from these treatments or whether these treatments are effective for a wider group of children with ASD
But responses may vary between individuals
